Llinos Honeybun
Llinos Honeybun has recently completed her PhD investigating novel therapeutics for CLN3 disease (awaiting viva) and is currently working as an associate researcher in the lysosomal disorder field. Her PhD project was conducted at Cardiff University under the supervision of Prof. Emyr Lloyd-Evans. Prior to undertaking a PhD, she studied pharmacology as an undergraduate at the University of Bath before undertaking a master's degree in forensic science at Strathclyde University, Glasgow.
Abstracts this author is presenting:
